GISAID
Sign in to saveGISAID (), the Global Initiative on Sharing All Influenza Data, previously the Global Initiative on Sharing Avian Influenza Data, is a global science initiative established in 2008 to provide access to genomic data of influenza viruses. The database was expanded to include the coronavirus responsible for the COVID-19 pandemic, as well as other pathogens. The database has been described as "the world's largest repository of COVID-19 sequences". GISAID facilitates genomic epidemiology and real-time surveillance to monitor the emergence of new COVID-19 viral strains across the planet.
Key facts
- Organization.logo
- GISAID logo.png
- Organization.full_name
- Global Initiative on Sharing All Influenza Data
- Organization.type
- Nonprofit organization
- Organization.purpose
- Global health, research
- Organization.headquarters
- Munich, Germany
- Organization.website
- https://gisaid.org
- Organization.name
- GISAID
- Organization.method
- Donations and grants
via Wikipedia infobox
Article
10 sectionsContents
- History
- Origin
- 2009 onwards
- Database for SARS-CoV-2 genomes
- Governance
- Access and intellectual property
- See also
- References
- Further reading
- External links
GISAID (), the Global Initiative on Sharing All Influenza Data, previously the Global Initiative on Sharing Avian Influenza Data, is a global science initiative established in 2008 to provide access to genomic data of influenza viruses. The database was expanded to include the coronavirus responsible for the COVID-19 pandemic, as well as other pathogens. The database has been described as "the world's largest repository of COVID-19 sequences". GISAID facilitates genomic epidemiology and real-time surveillance to monitor the emergence of new COVID-19 viral strains across the planet.
Since its establishment as an alternative to sharing avian influenza data via conventional public-domain archives, GISAID has facilitated the exchange of outbreak genome data during the H1N1 pandemic in 2009, the H7N9 epidemic in 2013, the COVID-19 pandemic and the 2022–2023 mpox outbreak.